Confirmatory Study of MT-2412 in Japanese Patients With Type 2 Diabetes (Add-on Study of Canagliflozin)

Clinical trial NCT02354235 · COMPLETED

Trial details

NCT number: NCT02354235
Sponsor: Tanabe Pharma Corporation
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2015-01-01
Primary completion: 2016-01-01
Enrollment: 138

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.